On September 12, Discern attended the National Comprehensive Cancer Network (NCCN) Policy Summit: Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer Care. The summit presented diverse perspectives related to defining, measuring, and paying for quality as cancer care is inundated with innovative, personalized, and high-cost interventions.
Experts in the field discussed the role of outcomes-based oncology quality measures in policy decision-making, including how the patient experience is considered and applied in clinical decision-making. The summit also evaluated how clinical utility and personalized medicine outcomes shape the health care system. Key themes from the discussion include increasing drug costs, the impact and sustainability of the Oncology Care Model, and the current role and future implications of quality measurement.
Download a summary of the summit here.
Download the Rising Drug Costs: Challenges in Controlling Overall Cost of Care presentation slides here and The Role of Standardized Performance Measures in Ensuring Quality in Cancer Care presentation slides here.